ReviewInflammopharmacology2023

Selective inhibition of peptidyl-arginine deiminase (PAD): can it control multiple inflammatory disorders as a promising therapeutic strategy?

Dibya Sundar Padhy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.